Article Information
History
- February 7, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Sho Nakakubo, M.D., Ph.D.1,*,#,
- Naoki Kishida, M.D., Ph.D.2,*,
- Kenichi Okuda, M.D., Ph.D.3,*,
- Keisuke Kamada, M.D., Ph.D.1,4,5,
- Masami Iwama6,
- Masaru Suzuki, M.D., Ph.D.1,
- Isao Yokota, Ph.D.7,
- Yoichi M. Ito, Ph.D.8,
- Yasuyuki Nasuhara, M.D., Ph.D.9,
- Richard C. Boucher, M.D.3 and
- Satoshi Konno, M.D., Ph.D.1,10
- 1Department of Respiratory Medicine, Faculty of Medicine, Hokkaido University, Sapporo, Japan
- 2Emergency Management Bureau, City of Sapporo, Sapporo, Japan
- 3Marsico Lung Institute/Cystic Fibrosis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
- 4Department of Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan
- 5Department of Epidemiology and Clinical Research, The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan
- 6Management Section, Medical Management Office, Health and Welfare Bureau, City of Sapporo, Sapporo, Japan
- 7Department of Biostatistics, Graduate School of Medicine, Hokkaido University, Sapporo, Japan
- 8Data Science Center, Promotion Unit, Institute of Health Science Innovation for Medical Care, Hokkaido University Hospital, Sapporo, Japan
- 9Division of Hospital Safety Management, Hokkaido University Hospital, Sapporo, Japan
- 10Hokkaido University, Institute for Vaccine Research and Development
- ↵#Corresponding author: Sho Nakakubo, MD, PhD, Department of Respiratory Medicine, Faculty of Medicine, Hokkaido University, North 15 West 7, Kita-ku, Sapporo 060-8638, Japan, E-mail: shonakakubo{at}pop.med.hokudai.ac.jp, Tel: +81-11-706-5911
↵* (These authors equally contributed to the work)
Posted February 07, 2023.
Associations of COVID-19 Symptoms with Omicron Subvariants BA.2 and BA.5, Host Status, and Clinical Outcomes: A Registry-Based Observational Study in Sapporo, Japan
